001     908587
005     20230123110631.0
024 7 _ |a 10.3390/cancers14143336
|2 doi
024 7 _ |a 2128/31518
|2 Handle
024 7 _ |a 35884396
|2 pmid
024 7 _ |a WOS:000831654800001
|2 WOS
037 _ _ |a FZJ-2022-02703
082 _ _ |a 610
100 1 _ |a Heinzel, Alexander
|0 P:(DE-Juel1)132315
|b 0
|u fzj
245 _ _ |a Two Decades of Brain Tumour Imaging with O-(2-[18F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich Experience
260 _ _ |a Basel
|c 2022
|b MDPI
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1658488808_6966
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a PET using radiolabelled amino acids has become an essential tool for diagnosing brain tumours in addition to MRI. O-(2-[18F]fluoroethyl)-L-tyrosine (FET) is one of the most successful tracers in the field. We analysed our database of 6534 FET PET examinations regarding the diagnostic needs and preferences of the referring physicians for FET PET in the clinical decision-making process. The demand for FET PET increased considerably in the last decade, especially for differentiating tumour progress from treatment-related changes in gliomas. Accordingly, referring physicians rated the diagnostics of recurrent glioma and recurrent brain metastases as the most relevant indication for FET PET. The analysis and survey results confirm the high relevance of FET PET in the clinical diagnosis of brain tumours and support the need for approval for routine use.
536 _ _ |a 5253 - Neuroimaging (POF4-525)
|0 G:(DE-HGF)POF4-5253
|c POF4-525
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Dedic, Daniela
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Galldiks, Norbert
|0 P:(DE-Juel1)143792
|b 2
|u fzj
700 1 _ |a Lohmann, Philipp
|0 P:(DE-Juel1)145110
|b 3
700 1 _ |a Stoffels, Gabriele
|0 P:(DE-Juel1)131627
|b 4
|u fzj
700 1 _ |a Filss, Christian P.
|0 P:(DE-Juel1)141877
|b 5
|u fzj
700 1 _ |a Kocher, Martin
|0 P:(DE-Juel1)173675
|b 6
|u fzj
700 1 _ |a Migliorini, Filippo
|0 0000-0001-7220-1221
|b 7
700 1 _ |a Dillen, Kim N. H.
|0 P:(DE-Juel1)136676
|b 8
700 1 _ |a Geisler, Stefanie
|0 P:(DE-Juel1)131773
|b 9
700 1 _ |a Stegmayr, Carina
|0 P:(DE-Juel1)156479
|b 10
|u fzj
700 1 _ |a Willuweit, Antje
|0 P:(DE-Juel1)144347
|b 11
700 1 _ |a Sabel, Michael
|0 P:(DE-Juel1)165921
|b 12
700 1 _ |a Rapp, Marion
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Eble, Michael J.
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Piroth, Marc
|0 P:(DE-HGF)0
|b 15
700 1 _ |a Clusmann, Hans
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Delev, Daniel
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Bauer, Elena K.
|0 P:(DE-HGF)0
|b 18
700 1 _ |a Ceccon, Garry
|0 P:(DE-HGF)0
|b 19
700 1 _ |a Dunkl, Veronika
|0 P:(DE-Juel1)156211
|b 20
700 1 _ |a Rosen, Jurij
|0 P:(DE-HGF)0
|b 21
700 1 _ |a Tscherpel, Caroline
|b 22
700 1 _ |a Werner, Jan-Michael
|0 0000-0001-7147-4594
|b 23
700 1 _ |a Ruge, Maximilian I.
|0 P:(DE-HGF)0
|b 24
700 1 _ |a Goldbrunner, Roland
|0 P:(DE-HGF)0
|b 25
700 1 _ |a Hampl, Jürgen
|0 P:(DE-HGF)0
|b 26
700 1 _ |a Weiss Lucas, Carolin
|0 P:(DE-HGF)0
|b 27
700 1 _ |a Herrlinger, Ulrich
|0 P:(DE-HGF)0
|b 28
700 1 _ |a Maurer, Gabriele D.
|0 P:(DE-HGF)0
|b 29
700 1 _ |a Steinbach, Joachim P.
|0 P:(DE-HGF)0
|b 30
700 1 _ |a Mauler, Jörg
|0 P:(DE-Juel1)144215
|b 31
700 1 _ |a Worthoff, Wieland A.
|0 P:(DE-Juel1)156200
|b 32
700 1 _ |a Neumaier, Bernd N.
|0 P:(DE-Juel1)166419
|b 33
700 1 _ |a Lerche, Christoph
|0 P:(DE-Juel1)164254
|b 34
700 1 _ |a Fink, Gereon Rudolf
|0 P:(DE-Juel1)131720
|b 35
|u fzj
700 1 _ |a Shah, N. J.
|0 P:(DE-Juel1)131794
|b 36
|u fzj
700 1 _ |a Mottaghy, Felix M.
|0 P:(DE-Juel1)132318
|b 37
|u fzj
700 1 _ |a Langen, Karl-Josef
|0 P:(DE-Juel1)131777
|b 38
|e Corresponding author
773 _ _ |a 10.3390/cancers14143336
|g Vol. 14, no. 14, p. 3336 -
|0 PERI:(DE-600)2527080-1
|n 14
|p 3336 -
|t Cancers
|v 14
|y 2022
|x 2072-6694
856 4 _ |u https://juser.fz-juelich.de/record/908587/files/cancers-14-03336-v2.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:908587
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)132315
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)143792
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)145110
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)131627
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 5
|6 P:(DE-Juel1)141877
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-Juel1)173675
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 9
|6 P:(DE-Juel1)131773
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 10
|6 P:(DE-Juel1)156479
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 11
|6 P:(DE-Juel1)144347
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 31
|6 P:(DE-Juel1)144215
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 32
|6 P:(DE-Juel1)156200
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 33
|6 P:(DE-Juel1)166419
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 34
|6 P:(DE-Juel1)164254
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 35
|6 P:(DE-Juel1)131720
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 36
|6 P:(DE-Juel1)131794
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 37
|6 P:(DE-Juel1)132318
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 38
|6 P:(DE-Juel1)131777
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5253
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-05-04
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-05-04
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-05-04
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-05-04
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCERS : 2021
|d 2022-11-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2022-01-24T07:56:58Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2022-01-24T07:56:58Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2022-01-24T07:56:58Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-30
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-30
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CANCERS : 2021
|d 2022-11-30
920 1 _ |0 I:(DE-Juel1)INM-4-20090406
|k INM-4
|l Physik der Medizinischen Bildgebung
|x 0
920 1 _ |0 I:(DE-Juel1)INM-11-20170113
|k INM-11
|l Jara-Institut Quantum Information
|x 1
920 1 _ |0 I:(DE-Juel1)VDB1046
|k JARA-BRAIN
|l Jülich-Aachen Research Alliance - Translational Brain Medicine
|x 2
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 3
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-4-20090406
980 _ _ |a I:(DE-Juel1)INM-11-20170113
980 _ _ |a I:(DE-Juel1)VDB1046
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21